ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,265Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 459

$358K Total Retail Price of All Prescriptions

Rank: 45 out of 459

328 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 328 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 3,756 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
OMEPRAZOLE 448 169 1 3
LISINOPRIL 386 178 2 4
LEVOTHYROXINE SODIUM 344 139 3 5
HYDROCODONE-ACETAMINOPHEN 307 120 S3 4 2
TRAMADOL HCL 306 120 5 13
SIMVASTATIN 294 131 6 1
GABAPENTIN 284 122 7 10
HYDROCHLOROTHIAZIDE 252 126 8 9
ATENOLOL 233 125 9 14
METFORMIN HCL 189 67 10 7
LOVASTATIN 179 88 11 37
RANITIDINE HCL 172 50 12 29
CYCLOBENZAPRINE HCL 153 49 R 13 41
SERTRALINE HCL 152 54 14 20
NEXIUM 146 33 15 16
AMITRIPTYLINE HCL 131 35 R 16 44
IBUPROFEN 128 28 17 65
FUROSEMIDE 119 61 18 8
QUINAPRIL HCL 117 66 19 173
SPIRONOLACTONE 114 64 20 56
GEMFIBROZIL 112 28 21 109
PRAVASTATIN SODIUM 110 68 22 12
POTASSIUM CHLORIDE 109 54 23 24
FLUTICASONE PROPIONATE 103 49 24 36
PROAIR HFA 101 40 25 32
ESCITALOPRAM OXALATE 96 29 26 61
GLIPIZIDE 86 55 27 51
SINGULAIR 84 15 28 66
CITALOPRAM HBR 83 0 29 18
AZITHROMYCIN 82 20 30 25
ATORVASTATIN CALCIUM 81 38 31 15
AMLODIPINE BESYLATE 81 47 31 6
BUSPIRONE HCL 78 17 33 105
ALENDRONATE SODIUM 78 62 33 48
ZETIA 77 36 35 62
MELOXICAM 72 29 36 34
DICLOFENAC SODIUM 70 29 37 103
LANTUS 66 33 38 81
CIPROFLOXACIN HCL 65 37 39 50
METOPROLOL TARTRATE 64 27 40 11
ENALAPRIL MALEATE 58 29 41 77
NAPROXEN 55 15 42 104
ADVAIR DISKUS 53 21 43 53
CLONIDINE HCL 52 0 44 60
VERAPAMIL HCL 51 34 45 284
DIOVAN 50 16 46 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.